Migration features of labeled bone marrow mesenchymal stem cells in rats with modeled Parkinson-like syndrome
Keywords:Parkinson-like syndrome, bone marrow mesenchymal stem cells, transplantation, fluorochrome-labeled cells, cell migration, experiment.
The purpose. To study localization of bone marrow mesenchymal stem cells (BM MSC), labeled by green (DiO C18) and red (Rhod Chol) vital fluorochromes, after intravenous (IV) and intracerebral (IC) transplantation into rats with modeled Parkinson-like syndrome (PS).
Materials and methods. The animals were divided into 3 groups, each of 6: I — control, IV and IC administration of labeled BM MSC; II — PS model and IV administration of green BM MSC; III — PS and IC transplantation of red BM MSC. Cell transplantation was performed on the 7th day after PS modeling. MSCs transplantation effectiveness was assessed by decrease of motor disorders degree, localization of fluorochrome labeled cells in the organs of rats was detected on cryosections of brain, lung, spleen, heart, kidneys and liver on the 4th and 9th day after MSC injection using fluorescence microscope.
Results. Fluorescent vital dyes DiO C18 (green) and Rhod Chol (red) can be effectively used to study MSCs properties in culture and their migration in the body of experimental animals. Selective migration of transplanted labeled BM MSCs to damaged areas of the brain damage at PS modeling in rats was shown.
Conclusions. For MSCs delivery in the brain damaged area their IC and less invasive IV transplantation can be used.
Pyatikop VA. Neyrokhirurgicheskaya korrektsiya dvigatel'nykh rasstroystv pri parkinsonizme (eksperimental'noye i klinicheskoye issledovaniye). [The neurosurgical correction of movement disorders at Parkinson disease (experimental and clinical research)]. [dissertation]. Kiev (Ukraine): Romodnov Neurosurgery Institute; 2009. Russian.
Ehnert S, Glanemann M, Schmitt A, Vogt S, Shanny N, Nussler NC, Stцckle U, Nussler A. The possible use of stem cells in regenerative medicine: dream or reality. Langenbecks Arch. Surg. 2009;394(6):985-997. [CrossRef] [PubMed]
Shchegelskaya EA, Pyatikop VA, Mikulinsky YuE. Induktsiya stromal'nykh kletok kostnogo mozga v neyroblasty i ikh ispol'zovaniye v lechenii patsiyentov s bolezn'yu Parkinsona [Induction of bone marrow stromal cells to neuroblasts and their use in Parkinson's disease treatment]. In : Abstract Book of III Transplant Congress of Ukraine; 2004 October 5-8; Donetsk, Ukraine. Donetsk, 2004. p.381-384. Russian.
Yavorskaya VA, Voloshina NP, Khvysyuk VV, Grebenyuk AV, Gavryushin AYu, Gretskych KV, Pelekhova OL, Mikulinsky YuE, Vasilovskiy VV, Shestopalova LF, Shchegelskaya EA. [Receiving of neuroblasts from bone marrow stromal cells and its clinical application in patients with some diseases of nervous system]. Ukrainian Neurosurgical Journal. 2006;(4):89-96. Russian.
Hayashi T, Wakao S, Kitada M, Ose T, Watabe H, Kuroda Y, Mitsunaga K, Matsuse D, Shigemoto T, Ito A, Ikeda H, Fukuyama H, Onoe H, Tabata Y, Dezawa M. Autologous mesenchymal stem cell-derived dopaminergic neurons function in parkinsonian macaques. J. Clin. Invest. 2013;123(1):272-284. [CrossRef] [PubMed]
Hofstetter CP, Schwarz EJ, Hess D, Widenfalk J, El Manira A, Prockop DJ, Olson L. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proceedings of the National Academy of Sciences. 2002;99(4):2199-2204. [CrossRef]
Meleshina AV, Cherkasova EI, Sergeeva EA, Kleshnin MS, Turchin IV, Kiseleva EV, Dashinimaev EV, Shirmanova MV, Luk’yanov SA, Zagajnova EV. Issledovaniye vzaimodeystviya mezenkhimal'nykh stvolovykh kletok i opukholi metodami fluorestsentnogo bioimidzhinga [Investigation of mesenchymal stem cells and tumors interaction using fluorescence bioimaging]. Sovrem. tehnologii v meditsine. 2012;(4):7-16.
Marlene P, Muriel G, Eliane M, Rafii A, Benabbou N, Mirshahi P, Hennebelle I, Bourin P, Allal B, Teissie J, Mirshahi M, Couderc B. Hospicells (ascites-derived stromal cells) promote tumorigenicity and angiogenesis. Int. J. Cancer. 2010;126(9):2090-2101. [CrossRef] [PubMed]
Zinkova NN, Gilerovitch EG, Sokolova IВ, Vijde SK, Shvedova EV, Alexandrov GV, Kruglyakov PV, Kislyakova TV, Polyntsev DG. [Mesenchymal stem cells-based therapy of brain ischemic stroke in rat ] [Internet]. Tsitologiya. 2007;49(7):566-575. Available from: http://www.tsitologiya.cytspb.rssi.ru/49_7/zinkova_en.htm
Pyatikop VA, Shchegelskaya EA, Mikulinsky YuE. Vosstanovleniye strukturno-funktsional'nykh parametrov u krys s kriogennoy travmoy golovnogo mozga posle transplantatsii kletok stromy kostnogo mozga, indutsirovannykh v neyroblasty [Structural and functional parameters renewing in rats with cryogenic brain injury after transplantation of bone marrow stromal cells induced to neuroblasts]. Probl. kriobiologii. 2005;15(3):449-451.
Jeon BS, Jackson-Lewis V, Burke RE. 6-Hydroxydopamine lesion of the rat substantia nigra: Time course and morphology of cell death. Neurodegeneration. 1995;4(2):131-137. [PubMed]
Fifkova E, Marsala J. Stereotaxic atlases for the cat, rabbit, and rat brain. Praha: SZN; 1960.
Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of Traumatic Brain Injury in Female Rats with Intravenous Administration of Bone Marrow Stromal Cells. Neurosurgery. 2001;49(5):1196-1204. [CrossRef] [PubMed]
Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M. Intraarterial Administration of Marrow Stromal Cells in a Rat Model of Traumatic Brain Injury. Journal of Neurotrauma. 2001;18(8):813-819. [CrossRef] [PubMed]
How to Cite
Copyright (c) 2014 Vladimir Pyatikop, Mohammad Ahmad Msallam Jr, Elena Shchegelskaya, Igor Kutovoy, Galina Gubina-Vakulik
This work is licensed under a Creative Commons Attribution 4.0 International License.
Ukrainian Neurosurgical Journal abides by the CREATIVE COMMONS copyright rights and permissions for open access journals.
Authors, who are published in this Journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the Journal under the terms of Creative Commons Attribution License, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this Journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form of which it has been published by the Journal (for example, to upload the work to the online storage of the Journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this Journal is included.